Renaissance Technologies
THRD

Renaissance Technologies’s Third Harmonic Bio THRD Stock Holding History

Renaissance Technologies’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-331,800
Closed -$1.15M – 3898
2025
Q1 		$1.15M Buy
331,800
+204,094
+160% +$990K ﹤0.01% 2329
2024
Q4 		$1.31M Buy
127,706
+23,046
+22% +$287K ﹤0.01% 2326
2024
Q3 		$1.42M Sell
104,660
-5,540
-5% -$68.6K ﹤0.01% 2239
2024
Q2 		$1.43M Buy
110,200
+41,900
+61% +$518K ﹤0.01% 2101
2024
Q1 		$645K Buy
68,300
+55,300
+425% +$538K ﹤0.01% 2759
2023
Q4 		$143K Buy
+13,000
New +$103K ﹤0.01% 3223

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Renaissance Technologies's THRD Position: Q2 2025 in Review

Renaissance Technologies sold out of Third Harmonic Bio (THRD) in Q2 2025, closing a stake of 331,800 shares — an estimated $1.15M sold.

Renaissance Technologies first reported a position in THRD in Q4 2023 and held it in 6 quarters. The position peaked at $1.43M in Q2 2024. 105 funds tracked by Wall St. Rank hold THRD as of Q2 2025.

  • Renaissance Technologies reported no remaining Third Harmonic Bio position as of Q2 2025 after selling out during the quarter.
  • Renaissance Technologies sold 331,800 Third Harmonic Bio shares in Q2 2025, an estimated $1.15M.
  • Renaissance Technologies first reported a position in Third Harmonic Bio in Q4 2023 and held it in 6 quarters.
  • Renaissance Technologies's Third Harmonic Bio position peaked at $1.43M in Q2 2024.
  • 105 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2025.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.